Metabolomic and BH3 profiling of esophageal cancers: novel assessment methods for precision therapy

Metabolomic and BH3 profiling of esophageal cancers: novel assessment methods for precision therapy

Abstract Background Esophageal cancers accounted for nearly 16,000 deaths in 2016. The number of patients with esophageal cancers increases every year. Neoadjuvant chemoradiotherapy (nCRT) prior to esophagectomy is a standard treatment for esophageal cancers. The patients who have no residual tumor...

Full description

Bibliographic Details
Main Authors: R. Taylor Ripley, Deborah R. Surman, Laurence P. Diggs, Jane B. Trepel, Min-Jung Lee, Jeremy Ryan, Jeremy L. Davis, Seth M. Steinberg, Jonathan M. Hernandez, Choung Hoang, Cara M. Kenney, Colleen D. Bond, Tricia F. Kunst, Anthony Letai, David S. Schrump
Format: Article
Language:English
Published: BMC 2018-06-01
Series:BMC Gastroenterology
Subjects:
Esophageal adenocarcinoma
Esophageal squamous cell carcinoma
Pathologic complete response
BH3 profiling
Metabolomics
Online Access:http://link.springer.com/article/10.1186/s12876-018-0823-x

Internet

http://link.springer.com/article/10.1186/s12876-018-0823-x

Similar Items